期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

非小细胞肺癌表皮生长因子受体分子影像研究进展 被引量：2

原文传递
导出
摘要 肺癌是全球累积危险性最高的肿瘤，每年有超过135万的新发病例，近120万人死于这一疾病，死亡人数超过乳腺癌、结肠癌和前列腺癌三者死亡人数的总和。由于肺癌的早期诊断方法至今没有突破性的进展，确诊后仅少数患者具备手术切除条件，因此，放、化疗在肺癌的治疗中占有重要地位。但传统放、化疗对肺癌的疗效有限，患者常出现难以忍受的毒副反应，
作者 于金明 刘宁波
机构地区 山东省肿瘤医院放疗科
出处 《中华肿瘤杂志》 CAS CSCD 北大核心 2009年第2期81-84,共4页 Chinese Journal of Oncology
基金 国家高技术发展计划（2007AA02Z437）
关键词 分子影像 表皮生长因子受体 非小细胞肺癌 Molecular imaging Epidermal growth factor receptor Non-small cell lung cancer
分类号 R686 [医药卫生—骨科学]
  • 相关文献

参考文献3

二级参考文献22

  • 1Tsai CM, Chang KT, Wu LH, et al. Correlations between intrinsic chemoresistance and HEH-2/neu gene expression, p53 gene mutations,and cell proliferation characteristics in non-small cell lung cancer celllines. Cancer Res, 1996,56:206-209.
  • 2Fukuoka M, Yano S, Giaccone G, et al. Multi-institutional randomized phase Ⅱ trial of gefitinib for previously treated patients with advanced non-small-call lung cancer. J Clin Oncol, 2003, 21 :2237 -2246.
  • 3Herbst RS, Maddox AM, Rothenherg ML, et al. Selective oral epidermal growth factor receptor tyrosine kinase inhibitor ZD1839 is generally well-tolerated and has activity in non-small-cell lung cancer and other solid tumors: results of a phase Ⅰ trial. J Clin Oncol, 2002, 20:3815-3825.
  • 4Ciardiello F, Caputo R, Bianco R, et al. Inhibition of growth factor production and angiogenesis in human cancer cells by ZD1839(Iressa), a selective epidermal growth factor receptor tyrosine kinase inhibitor. Clin Cancer Res, 2001, 7 : 1459-1465.
  • 5Ryan PD, Chabner BA. On receptor inhibitors and chemotherapy.Clin Cancer Res, 2000, 6:4607-4609.
  • 6Nicholson RI, Gec JM, Harper ME. EGFR and cancer prognosis.Eur J Cancer, 2001, 37(Suppl 4) :S9-15.
  • 7Schmidt M, Maurer-gebhard M, Groner B, et al. Suppression of metastasis formation by a recombinant single chain antibody-toxin targeted to full-length and oncogenic variant EGF receptors.Oncogene, 1999, 18 : 1711-1721.
  • 8Kris MG, Natale BB, Herbst RS, et al. Efficacy of gefitinib, an inhibitor of the epidermal growth factor receptor tyrosine kinase, in symptomatic patients with non-small cell lung cancer: a randomized trial. JAMA, 2003, 290:2149-2158.
  • 9Tamura K, Fukuoka M. Gefitinib in non-small cell lung cancer.Expert Opin Pharmacother, 2005, 6:985-993.
  • 10Giovanni Lucignani,Barbara A. Jereczek-Fossa,Roberto Orecchia.The role of molecular imaging in precision radiation therapy for target definition, treatment planning optimisation and quality control[J].European Journal of Nuclear Medicine and Molecular Imaging.2004(8)

共引文献48

同被引文献18

  • 1柏朋刚,张秀春,潘建基,李慧灵,张春,张瑜.静态调强适形放射治疗设计及30例剂量验证分析[J].福建医科大学学报,2006,40(3):248-251. 被引量：8
  • 2薄爱华,程琳,李海峰,赵荧,张晓丽,邢立强.表皮生长因子受体与肿瘤发生及治疗的相关性[J].医学综述,2006,12(20):1238-1240. 被引量：15
  • 3肖锋,孙朝阳,石梅,张学成,陆宙,陆军,刘晓莉.鼻咽癌动态调强放疗计划的剂量学验证[J].现代肿瘤医学,2007,15(2):178-180. 被引量：17
  • 4Schippinger W,Dandachi N,Regitnig P,et al.The predictive value of EGFR and HER-2/neu in tumor tissue and serum for response to anthracycline-based neoadjuvant chemotherapy of breast cancer[J].Am J Clin Pathol,2007,128(4):630-637.
  • 5Xie FH,Wang RX.The research progress of the relationship between the way of EGFR family's signal transfer and breast cancer[J].Int J Lab Med,2006,27(11):1004-1008.
  • 6Huang S,Armstrong EA,Benavente S,et al.Dual-agent molecular targeting of the epidermal growth factor receptor(EGFR):combining anti-EGFR antibody with tyrosine kinase inhibitor[J].Cancer Res,2004,64(15):5355-5362.
  • 7Bianco R,Damiano V,Gelardi T,et al.Rational combination of targeted therapies as a strategy to overcome the mechanisms of resistance to inhibitors of EGFR signaling[J].Curr Pharm Des,2007,13(33):3358-3367.
  • 8Ahmed SM,Cohen EE.Treatment of squamous cell carcinoma of the head and neck in the metastatic and refractory settings:advances in chemotherapy and the emergence of small molecule epidermal growth factor receptor kinase inhibi-tors[J].Curr Cancer Drug Targets,2007,7(7):666-673.
  • 9Armstrong EA,Benavents S.Dual-agent milecular targeting of the epidermal growth factor receptor(EGFR):combining anti-EGFR antibody with tyrosine kinase inhibitor[J].Cancer Res,2004,64(15):5355-5362.
  • 10张晓军,王建华,涂彧.二维电离室矩阵在调强适形放疗剂量学验证中的应用[J].国际放射医学核医学杂志,2007,31(5):318-320. 被引量：12

引证文献2

二级引证文献11

中华肿瘤杂志
2009年 第2期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部